Kevin Kedra is a Research Analyst with GAMCO Investors. He joined GAMCO in 2005 as a research analyst covering the health care industry. He now covers animal health, biotech and pharma for GAMCO. He graduated from the University of Pennsylvania where he received a B.S.E. in bioengineering.
D.C. Drug Price Debate Creates Opportunity for Longer-Term Pharma Investors
September 30, 2021
Pharma M&A Activity Expected to Return in 2021
September 21, 2020
Pharmaceutical Companies Focusing More on Animal Health
November 27, 2015
